Discovery of a novel NUAK1 inhibitor against pancreatic cancer
Open Access
- 9 June 2022
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 152, 113241
Abstract
No abstract availableKeywords
Funding Information
- Korea Institute of Science and Technology (2E30240)
- National Research Foundation of Korea (2019M3E5D1A02069621)
- National Research Foundation of Korea (2021 R1A2B5B03086410)
- National Research Foundation of Korea (2021R1A5A2031612)
- Institute for Basic Science (IBS-R010-A2)
This publication has 41 references indexed in Scilit:
- Characterization of WZ4003 and HTH-01-015 as selective inhibitors of the LKB1-tumour-suppressor-activated NUAK kinasesBiochemical Journal, 2013
- Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategyTumor Biology, 2013
- Overexpression of ARK5 is associated with poor prognosis in hepatocellular carcinomaTumor Biology, 2013
- High NUAK1 expression correlates with poor prognosis and involved in NSCLC cells migration and invasionExperimental Lung Research, 2012
- Deregulated MYC expression induces dependence upon AMPK-related kinase 5Nature, 2012
- Magnolol, a natural compound, induces apoptosis of SGC-7901 human gastric adenocarcinoma cells via the mitochondrial and PI3K/Akt signaling pathwaysInternational Journal of Oncology, 2011
- ARK5 is associated with the invasive and metastatic potential of human breast cancer cellsJournal of Cancer Research and Clinical Oncology, 2011
- RB and cell cycle progressionOncogene, 2006
- LKB1-Dependent Signaling PathwaysAnnual Review of Biochemistry, 2006
- Cell cycle checkpoint signaling:Toxicology, 2002